GlaxoSmithKline Inc. v. Canada (Attorney General) et al., (2004) 263 F.T.R. 142 (FC)
Linked as:
Extract
GlaxoSmithKline Inc. v. Canada (Attorney General) et al., (2004) 263 F.T.R. 142 (FC)
No longer available (Autolink)
See the full content of this document
This document cites
- Deprenyl Research Ltd. et al. v. Apotex Inc. et al., (1994) 77 F.T.R. 62 (TD)
- Hoffmann-La Roche Ltd. et al. v. Canada (Minister of National Health and Welfare) et al., (1995) 97 F.T.R. 288 (TD)
- Whirlpool Corp. et al. v. Camco Inc. et al., (2000) 263 N.R. 88 (SCC)
- Glaxo Group Ltd. et al. v. Novopharm Ltd. et al., (1998) 144 F.T.R. 252 (TD)
- Eli Lilly Canada Inc. v. Canada (Attorney General), (2003) 235 F.T.R. 134 (TD)
